In the population approach, all pregnant women undergo routine ultrasound examination at a certain optimal gestational age. When a congenital anomaly is suspected, referral to establish a diagnosis and appropriate obstetric policy follows. The screening procedure currently advocated for routine evaluation of the fetal heart is the four-chamber view at 16 to 24 weeks of pregnancy. 3.6 The high-risk approach is generally accepted and offers extensive fetal echocardiography to selected women, in particular to those women with a history of congenital heart disease in their offspring or those who appear during routine screening to be carrying an affected fetus. '16 Anomalies encountered in the high-risk group tend to be more serious and complex. In addition to the fourchamber view, the cardiac connections and functional status are evaluated. '16 Obviously, this can only be accomplished by skilled experts during a lengthy and detailed examination.
To justify routine The letters a through j refer to corresponding probabilities in Table 1 . 0 = chance node; 0 = decision node; * = outcome; X = implicit action; minor = minor anomaly; major = major anomaly; CHD = congenital heart disease; screen = test result of prenatal ultrasound screening; tertiary = test result of extensive ultrasound examination. *This chance node could also be represented by a decision node as it is an option (parental) to terminate pregnancy after detection of a severe anomaly. 
Results
The impact of routine screening, in numbers per million second-trimester pregnancies, is given in Note. In the analysis a distinction is made between major and minor anomalies. The plausible range used in sensitivity analysis is given in parentheses. Major and minor are categories of congenital malformation according to which sensitivity and clinical course is varied in the model. Ellipsis points indicate estimates of variables or ranges of variables not examined in the current analysis. The letters a through j refer to corresponding probabilities in Figure 1 . aExpected prevalence at 20 weeks' gestation calculated; varies according to probability of intrauterine death given CHD.
bin the model a specificity of extensive fetal echocardiography of 100% is applied.
reduction (from 2005 to 3208). In addition, as a result of a higher sensitivity, fetal karyotyping is performed more often, causing an additional loss of 23 (affected) fetuses (increasing the number lost from 32 to 55). Also, a sizable number of the cases that otherwise would have resulted in intrauterine death or spontaneous abortion are now terminated (from 752 fewer to 1205 fewer). If sensitivity decreases, only a marginal effect remains. However, an identical number of women would have to be referred and go through an emotionally difficult period owing to a false-positive screening test.
Parental inclination toward termination of pregnancy in case of severe malformation appears to have an effect that is numerically comparable to increased sensitivity of routine ultrasound. Obviously, with an increased proportion of the parents opting for termination of pregnancy in case of a major anomaly, fewer affected neonates are bom. If all pregnancies are carried to term very little effect remains. Figure 2 shows the results of a two-way sensitivity analysis of the two major determinants of the impact of screening. The effect of simultaneously varying estimates of the sensitivity of routine fetal ultrasound and estimates of the proportion of parents opting for termination of pregnancy, both in case of a severely affected fetus (i.e., cases resulting in neonatal survival with severe congenital heart disease or cases ending in neonatal death), is demonstrated. The number of newboms with serious anomalies prevented increases with increasing sensitivity and with an increasing probability of termination of pregnancy. Sensitivity and probability of termination show a combined (multiplicative) effect.
Variation in the probability of abnormal development of pregnancy or pregnancy pathology in affected fetuses does not appear to have any significant impact. Neither does variation in the probability of intrauterine death. We assumed the birth prevalence of congenital heart disease to remain stable. Accordingly, an increased probability of premature death implies that a larger number of pregnancies are terminated that would otherwise result in intrauterine death. Also, a larger number of affected fetuses would be lost sensitivity of routine screening for major anomalies FIGURE 2-Results of the two-way sensitivity analysis for the sensitivity of routine screening for major anomalies and the probability of termination of pregnancy (impact of screening vs no screening on number of newborns with serious anomalies prevented).
Discussion
We have shown that routine fetal ultrasound screening does not meet the generally held expectations. The fundamental idea of screening is that parents, neonates, and society in general may benefit from effective screening. One tion of pregnancies terminated on account of serious congenital heart disease will depend strongly on such an opinion or preference. In other words, the impact of screening will vary with local legal and ethical standards and attitudes.
We are aware of the fact that the basis for some of the other variables examined was uncertain. However, the impact of variability of these estimates on the expected distribution of outcomes of pregnancy in a low-risk population appeared to be limited. Moreover, the test characteristics of extensive structural ultrasound can already be considered more or less optimal, as are the complication rates of fetal karyotyping. Also, the actual prevalence, the natural history, and factors affecting the natural history of congenital malformations are hardly accessible to intervention. If they were accessible, this would imply possibilities for primary prevention.
Finally, an additional remark should be made regarding the specificity of extensive fetal echocardiography. The specificity applied in the model was presumed to be 100%. Therefore, farreaching consequences of false-positive routine screening tests are absent in the model and in the results presented. This may not be quite correct. Recently, cases have been described of fetuses with apparently severe congenital heart disease that proved to have only mild to moderate anomalies postnatally.30 A false-positive rate of extensive fetal echocardiography of 1% (specificity 99%) would result in approximately 100 such cases (1% of 9897) in the hypothetical cohort. Future parents erroneously presented with a serious prognosis who opted to terminate pregnancy would lose a normal fetus.
Overall, the yield of prenatal screening for congenital heart disease by means of the fetal four-chamber view, expressed as the prevention of the birth of a critically ill neonate, appears to be numerically small. With substantial effort the efficacy of routine screening may be improved. However, the results would still be modest. Moreover, the final decision parents make once a serious fetal anomaly is detected is culturally, socially, and economically determined. Evidently, a generally applicable protocol for termination of pregnancy is unrealistic.
The significance and valuation of the cases detected, cases not detected, and false-positive test results and their subsequent outcomes have not been assessed in the present analysis. Such an assessment may be attempted by estimating the psychological relief or burden perceived by the parents. Additionally, the costs of screening and postnatal costs could be weighed against the effects. In conclusion, routine fetal ultrasound screening for congenital heart disease does not seem warranted at present. Public health, in particular neonatal health, is not likely to improve if prenatal screening is offered in low-risk pregnancies. The public expenditures involved could more effectively be spent otherwise. C:
